Saturday 17 October 2026
Export RVTY’s income statement to Excel — free account
Revvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
152.64
2.07
−1.34%
Follow RVTY
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
24.88 | 28.00 | 36.88 | 47.60 | 22.15 | 24.88 | 30.82 | 20.08 | 50.50 | 46.51 |
Piotroski F-Score |
7 | 3 | 7 | 6 | 6 | 4 | 5 | 5 | 6 | 6 |
P/S ratio |
2.74 | 3.60 | 3.13 | 3.73 | 6.01 | 6.10 | 5.38 | 5.01 | 4.97 | 3.95 |
Altman Z-Score |
3.19 | 2.47 | 2.88 | 3.07 | 3.67 | 2.83 | 2.62 | 2.43 | 2.88 | 2.49 |
Altman Z″-Score (non-manufacturers) |
4.04 | 2.60 | 3.09 | 3.18 | 3.58 | 3.01 | 3.45 | 3.70 | 4.33 | 3.86 |
P/FCF ratio |
17.07 | 32.42 | 33.95 | 38.07 | 19.33 | 17.70 | 30.22 | 2,808.13 | 25.53 | 22.35 |
Beneish M-Score |
(2.64) | (2.28) | (2.45) | (2.45) | (2.16) | (2.70) | (2.69) | (2.32) | (2.56) | (2.45) |
P/Operating CF |
39.01 | 63.39 | 54.48 | 50.00 | 33.19 | 69.60 | 127.95 | 70.04 | 78.64 | 61.97 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 80 |
P/B ratio |
2.69 | 3.24 | 3.36 | 3.82 | 4.28 | 3.27 | 2.41 | 1.75 | 1.79 | 1.56 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.07 | 4.40 | 3.75 | 4.38 | 6.61 | 7.25 | 6.57 | 5.84 | 5.69 | 4.75 |
EV/EBITDA |
16.34 | 24.24 | 19.76 | 21.02 | 16.38 | 17.23 | 17.79 | 21.72 | 20.10 | 17.71 |
EV/Operating CF |
18.51 | 34.40 | 33.48 | 34.79 | 19.72 | 19.66 | 31.99 | 176.04 | 24.97 | 23.29 |
EV/FCF |
19.09 | 39.62 | 40.71 | 44.73 | 21.25 | 21.02 | 36.91 | 3,276.43 | 29.23 | 26.91 |
Quick Ratio |
1.30 | 0.79 | 1.03 | 1.20 | 0.94 | 1.08 | 0.69 | 1.54 | 2.75 | 1.25 |
Current Ratio |
1.97 | 1.26 | 1.60 | 1.80 | 1.36 | 2.01 | 2.13 | 2.07 | 3.60 | 1.68 |
Net Debt/EBITDA |
1.73 | 4.41 | 3.28 | 3.13 | 1.48 | 2.72 | 3.22 | 3.10 | 2.55 | 3.00 |
Debt/Assets |
24.47% | 32.93% | 31.65% | 31.72% | 25.01% | 33.23% | 31.10% | 28.75% | 25.42% | 26.46% |
Debt/Equity |
0.49 | 0.80 | 0.73 | 0.74 | 0.53 | 0.70 | 0.60 | 0.50 | 0.41 | 0.44 |
Asset Turnover |
0.50 | 0.44 | 0.46 | 0.46 | 0.37 | 0.33 | 0.23 | 0.20 | 0.21 | 0.23 |
Operating CF/Net income |
1.50 | 0.99 | 1.31 | 1.60 | 1.23 | 1.50 | 1.19 | 0.13 | 2.32 | 2.42 |
Capex/Depreciation |
(0.10) | (0.33) | (0.27) | (0.34) | (0.29) | (0.24) | (0.18) | (0.19) | (0.20) | (0.18) |
Interest Coverage |
5.83 | (268.01) | 4.89 | 2.90 | 12.91 | 22.93 | 8.17 | 2.56 | 11.33 | 4.04 |
| 10.99% | 12.57% | 9.35% | 8.43% | 22.23% | 17.34% | 7.84% | 9.09% | 3.48% | 3.23% | |
| 5.55% | 5.64% | 3.94% | 3.64% | 10.04% | 8.22% | 3.91% | 5.01% | 2.08% | 1.96% | |
ROIC |
6.48% | 4.29% | 4.69% | 4.82% | 10.18% | 6.83% | 4.10% | 1.85% | 2.24% | 2.33% |
Return on Tangible Assets |
32.00% | 53.49% | 30.44% | 24.47% | 76.22% | 55.07% | 25.56% | 33.64% | 12.41% | 17.38% |
Average Days of Receivables |
73.43 | 89.32 | 83.13 | 91.79 | 158.31 | 67.51 | 67.54 | 83.97 | 83.78 | 95.17 |
Research and Development Expense of Revenue |
5.87% | 6.18% | 6.98% | 6.57% | 5.50% | 5.23% | 6.69% | 7.87% | 7.14% | 7.56% |
Selling, General and Administrative Expense of Revenue |
27.91% | 27.74% | 29.23% | 28.27% | 26.90% | 25.48% | 30.97% | 37.18% | 36.08% | 34.73% |
Intangible Assets out of Total Assets |
0.62 | 0.71 | 0.69 | 0.67 | 0.60 | 0.70 | 0.70 | 0.70 | 0.73 | 0.74 |
Share Based Compensation of Revenue |
0.81% | 1.13% | 1.04% | 1.09% | 1.01% | 0.78% | 1.56% | 1.51% | 1.37% | 0.80% |
Graham Net Nets |
(0.16) | (0.29) | (0.25) | (0.22) | (0.12) | (0.23) | (0.19) | (0.20) | (0.17) | (0.24) |
Graham Number |
30.70 | 36.79 | 33.47 | 34.14 | 69.89 | 105.72 | 77.66 | 88.39 | 55.73 | 53.96 |
Earnings Yield |
4.02% | 3.57% | 2.71% | 2.10% | 4.52% | 4.02% | 3.25% | 4.98% | 1.98% | 2.15% |
Free Cash Flow Yield |
5.86% | 3.08% | 2.95% | 2.63% | 5.17% | 5.65% | 3.31% | 0.04% | 3.92% | 4.47% |
Revenue per Share |
19.32 | 20.54 | 25.13 | 26.02 | 23.88 | 32.95 | 26.25 | 22.06 | 22.44 | 24.51 |
Operating CF per Share |
3.20 | 2.63 | 2.81 | 3.28 | 8.00 | 12.14 | 5.39 | 0.73 | 5.12 | 5.00 |
Capex per Share |
(0.10) | (0.35) | (0.50) | (0.73) | (0.53) | (0.74) | (0.68) | (0.65) | (0.71) | (0.63) |
Free Cash Flow per Share |
3.10 | 2.28 | 2.31 | 2.55 | 7.47 | 11.40 | 4.71 | 0.08 | 4.41 | 4.37 |
Cash per Share |
3.28 | 1.84 | 1.48 | 1.73 | 3.61 | 5.19 | 3.60 | 12.86 | 9.48 | 7.89 |
Shareholders Equity per Share |
19.67 | 22.79 | 23.38 | 25.39 | 33.50 | 61.48 | 58.52 | 63.13 | 62.46 | 62.21 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
19.67 | 22.79 | 23.38 | 25.39 | 33.50 | 61.48 | 58.52 | 63.13 | 62.46 | 62.21 |
Free Cash Flow |
339.91 | 250.46 | 255.81 | 282.69 | 832.82 | 1,324.73 | 594.18 | 9.90 | 541.65 | 509.41 |
Working Capital |
586.58 | 249.05 | 463.00 | 611.55 | 586.73 | 1,227.04 | 1,744.08 | 1,550.63 | 1,696.51 | 908.50 |
Capital Expenditures |
(10.70) | (37.99) | (55.23) | (80.78) | (59.35) | (86.02) | (85.63) | (81.37) | (86.65) | (73.52) |
Net Current Asset Value |
(933.18) | (2,388.32) | (2,155.93) | (2,350.36) | (1,985.90) | (5,418.53) | (3,458.42) | (2,690.83) | (2,376.00) | (2,678.30) |
EV/EBIT |
22.03 | 33.57 | 32.15 | 34.93 | 20.28 | 22.04 | 29.28 | 53.46 | 45.24 | 38.07 |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
Price to Operating Income |
19.69 | 27.47 | 26.81 | 29.73 | 18.45 | 18.56 | 23.97 | 45.82 | 39.51 | 31.62 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.70 | 0.38 | 0.64 | 0.75 | 0.56 | 0.72 | 0.99 | 0.86 | 0.90 | 0.86 |
Cash ROIC |
9.55% | 5.32% | 5.51% | 5.57% | 13.59% | 10.41% | 4.86% | 0.07% | 4.52% | 4.47% |
Accounts Receivable Turnover |
5.03 | 4.62 | 4.69 | 4.25 | 2.83 | 4.11 | 5.02 | 4.42 | 4.36 | 4.15 |
Accounts Payable Turnover |
7.13 | 6.07 | 6.49 | 6.51 | 3.31 | 4.27 | 4.42 | 5.08 | 6.55 | 7.32 |
Inventory Turnover |
4.35 | 3.95 | 4.17 | 4.28 | 2.14 | 2.96 | 3.18 | 2.91 | 3.06 | 3.46 |
Average Days of Payables |
55.70 | 68.51 | 56.12 | 57.87 | 128.05 | 85.06 | 75.33 | 61.53 | 50.21 | 52.41 |
Days of Inventory on Hand |
81.82 | 108.48 | 85.94 | 87.58 | 201.29 | 111.53 | 111.95 | 129.03 | 110.21 | 107.24 |
Average Receivables |
420.33 | 488.95 | 592.49 | 678.93 | 940.15 | 931.53 | 660.36 | 622.80 | 632.61 | 688.54 |
Average Payables |
154.51 | 195.06 | 221.52 | 228.40 | 281.59 | 326.07 | 298.82 | 238.47 | 185.79 | 176.46 |
Average Inventory |
253.17 | 299.26 | 345.01 | 347.64 | 435.75 | 470.23 | 415.68 | 416.76 | 397.82 | 373.54 |
Average Assets |
4,221.49 | 5,184.07 | 6,033.49 | 6,257.04 | 7,249.44 | 11,480.43 | 14,565.21 | 13,847.27 | 12,978.58 | 12,280.45 |
Average Common Equity |
2,132.01 | 2,328.38 | 2,544.07 | 2,699.39 | 3,274.66 | 5,438.37 | 7,262.06 | 7,627.81 | 7,769.81 | 7,458.62 |
Columns are period end dates